Plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas
Veronika Fedirko; Gail McKeown‐Eyssen; Charles N. Serhan; Elizabeth L. Barry; Robert S. Sandler; Jane C. Figueiredo; Dennis J. Ahnen; Robert S. Bresalier; Douglas J. Robertson; Carlton W. Anderson; John A. Baron
Author Information: Department of Epidemiology, Rollins School of Public Health, Winship Cancer Institute
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.